DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Magnevist (Gadopentetate) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (45)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Magnevist (Gadopentetate) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 45   Next >>

Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male

Reactions: Joint Contracture, Skin Disorder, Muscular Weakness, Hypoaesthesia, Skin Induration, Nephrogenic Systemic Fibrosis, Muscle Rigidity, Balance Disorder, Grip Strength Decreased, Musculoskeletal Stiffness, Oedema, Depression, Gait Disturbance, Asthenia, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-09-27
    End date: 2006-09-27

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Start date: 2003-11-28
    End date: 2003-11-28

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-11-20
    End date: 2006-11-20

Gadolinium IN Unspecified Drug

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-02-01
    End date: 2006-02-01

Magnevist
    Indication: Pancreatic Mass

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-08-06

Other drugs received by patient: Nephrocaps; Gabapentin; Phoslo; Toprol-XL; Reglan; Warfarin Sodium; Allopurinol; Insulin; Prevacid; Simvastatin



Possible Magnevist side effects in 50 year old female

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)

Reactions: Pain, Skin Induration, Skin Hyperpigmentation, Nephrogenic Systemic Fibrosis, Rash, Anxiety, Emotional Distress, Anhedonia, Skin Discolouration, Post Thrombotic Syndrome, Skin Mass, Ocular Icterus, Injury, Depression, Mobility Decreased

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Cardiac Imaging Procedure
    Start date: 2003-08-12
    End date: 2003-08-12

Magnevist
    Dosage: unk
    Indication: Renal Scan
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Other drugs received by patient: Clonidine; Sodium Bicarbonate; Calcium Carbonate; Lopressor; Sevelamer Hydrochloride; Atorvastatin; Warfarin Sodium; Rapamune; Epogen; Diltiazem; Benicar



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: male

Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Mobility Decreased, Extremity Contracture

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-11-13

Magnevist

Other drugs received by patient: Hectorol; Coumadin; Metoclopramide; Aspirin; Klor-CON



Possible Magnevist side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: 61 year old male, weighing 124.0 kg (272.8 pounds)

Reactions: Wheelchair User, Pain, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Induration, Paraesthesia, Skin Tightness, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia, Extremity Contracture, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 15 ml (daily dose), once,
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-08-11
    End date: 2000-08-11

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-01-01
    End date: 2005-01-01

Magnevist
    Dosage: 15 ml (daily dose), once,
    Start date: 2001-07-27
    End date: 2001-07-27

Other drugs received by patient: Nephrocaps; Phoslo; Metronidazole; Renagel; Coreg; Prinivil; Atenolol; Warfarin Sodium; Darvocet; Vancocin Hydrochloride; Sodium Bicarbonate; Iron [iron]; Amoxicillin; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Hydrocodone Bitartrate and Acetaminophen; Tylenol with Codein #3; Phoslo; Solivito N [vit C,vit H,b12,b9,b3,pantothenic Ac,b6,b2,b1 Hcl]; Aspirin; Vitamin B6; Coreg; Epogen; Diltiazem; Plendil; Plendil; Lisinopril



Possible Magnevist side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: 58 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Skin Exfoliation, Quality of Life Decreased, Pain, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Injury, Fibrosis, Blood Creatinine Increased, Extremity Contracture, Blister, Muscle Contracture, Rash Papular, Contrast Media Reaction, Skin Disorder, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Deformity, Skin Tightness, Skin Plaque, Emotional Distress, Anxiety, Burning Sensation, Renal Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist

Other drugs received by patient: Calcium Acetate; Irbesartan; Clonidine; Hydralazine HCL; Visipaque; Visipaque; Glipizide; Ferrous Sulfate TAB; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Metoprolol Tartrate; Sevelamer Hydrochloride; Terazosin Hydrochloride; Dovonex; Contrast Media; Contrast Media; Synthroid; Aspirin; Felodipine; Contrast Media; Lasix; Omniscan; Folic Acid; Iron; Insulin; EPO



Possible Magnevist side effects in male

Reported by a lawyer from United States on 2012-08-14

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Prohance
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-10-16
    End date: 2002-10-16

Contrast Media
    Indication: Diabetic Foot
    Start date: 2002-11-05
    End date: 2002-11-05

Magnevist
    Dosage: once
    Start date: 2002-11-15
    End date: 2002-11-15

Magnevist
    Dosage: once
    Start date: 2004-07-16
    End date: 2004-07-16

Contrast Media
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-10-16
    End date: 2002-10-16

Magnevist
    Dosage: once
    Indication: Angiogram
    Start date: 2005-01-25
    End date: 2005-01-25

Contrast Media
    Start date: 2005-01-14
    End date: 2005-01-14

Contrast Media
    Indication: Osteomyelitis
    Start date: 2002-11-05
    End date: 2002-11-05

Other drugs received by patient: Accupril; Epogen; Diatx; Fosrenol; Clonidine; Insulin Human; Temazepam; Sevelamer Hydrochloride; Vitamins NOS; Insulin; Coumadin; Minoxidil; Lasix; Calcium Acetate



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 15 ml, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Prohance
    Dosage: unk unk, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Gadolinium IN Unspecified Drug
    Indication: Osteomyelitis

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk unk, once
    Start date: 2005-01-25
    End date: 2005-01-25

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-15
    End date: 2002-11-15

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Diabetic Foot

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-01-14
    End date: 2005-01-14

Magnevist
    Dosage: 19 ml, once
    Start date: 2004-07-16
    End date: 2004-07-16

Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: male

Reactions: Pain, Abasia, Joint Contracture, Sensory Loss, Skin Hyperpigmentation, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Muscle Contracture, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Grip Strength Decreased, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-11-13

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Renal Transplant

Other drugs received by patient: Metoclopramide; Klor-CON; Hectorol; Coumadin; Aspirin



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient: male

Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist

Omniscan

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-11-13

Other drugs received by patient: Coumadin; Aspirin; Klor-CON; Metoclopramide; Hectorol



Possible Magnevist side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)

Reactions: Pain, Skin Induration, Nephrogenic Systemic Fibrosis, Scleroderma, Rash, Skin Hyperpigmentation, Emotional Distress, Anxiety, Skin Discolouration, Skin Mass, Injury, Scleral Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-08-12
    End date: 2003-08-12

Magnevist
    Dosage: unk
    Indication: Cardiac Imaging Procedure
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Indication: Renal Scan
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Start date: 2003-08-12
    End date: 2003-08-12

Other drugs received by patient: Warfarin; Lopressor; Sevelamer; Benicar; Atorvastatin; Rapamune; Diltiazem; Calcium Carbonate; Clonidine; Sodium Bicarbonate; Epogen



Possible Magnevist side effects in 47 year old female

Reported by a consumer/non-health professional from United States on 2012-07-24

Patient: 47 year old female

Reactions: Vomiting, Dyspnoea, Nausea, Unresponsive To Stimuli, Cardiac Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist



Possible Magnevist side effects in 79 year old female

Reported by a physician from United States on 2012-07-20

Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan
    Dosage: dose reported as eight 20ml vials (160ml)
    Start date: 2005-09-20
    End date: 2005-09-20

Multihance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Prohance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Multihance
    Indication: Angiogram

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Gadolinium Zeolite
    Start date: 2005-08-16
    End date: 2005-08-16

Omniscan
    Dosage: route reported as ^first via distal port and then via the proximal port^
    Indication: Angiogram
    Start date: 2003-12-04
    End date: 2003-12-04

Optimark
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2005-08-16
    End date: 2005-08-16

Optimark
    Indication: Angiogram

Gadolinium Zeolite
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2001-03-05
    End date: 2001-03-05

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-05-23
    End date: 2003-05-23

Prohance
    Indication: Angiogram

Magnevist
    Indication: Angiogram
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: dose reported as ^11^ 20ml vials
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-01
    End date: 2005-09-01

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar



Possible Magnevist side effects in

Reported by a consumer/non-health professional from United States on 2012-06-26

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist



Possible Magnevist side effects in 52 year old female

Reported by a physician from Japan on 2012-06-21

Patient: 52 year old female, weighing 35.0 kg (77.0 pounds)

Reactions: Pneumonia, Nephrogenic Systemic Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Start date: 2004-07-07
    End date: 2004-07-07

Omniscan
    Start date: 2005-09-09
    End date: 2005-09-09

Omniscan
    Start date: 2005-12-21
    End date: 2005-12-21

Omniscan
    Dosage: 7 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-24
    End date: 2003-09-24

Magnevist
    Dosage: 7 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-05-14
    End date: 2003-05-14

Omniscan
    Start date: 2005-08-03
    End date: 2005-08-03

Magnevist
    Indication: Aortic Stenosis
    Start date: 2004-03-17
    End date: 2004-03-17

Magnevist
    Dosage: 15 ml, once
    Start date: 2005-08-30
    End date: 2005-08-30

Magnevist
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: 15 ml, once
    Start date: 2005-05-25
    End date: 2005-05-25

Magnevist
    Dosage: 15 ml, once
    Start date: 2004-12-29
    End date: 2004-12-29

Magnevist
    Indication: Angiogram
    Start date: 2003-07-08
    End date: 2003-07-08

Omniscan
    Start date: 2003-11-26
    End date: 2003-11-26

Omniscan
    Start date: 2005-03-16
    End date: 2005-03-16

Other drugs received by patient: Lidocaine; Levothyroxine Sodium; Pursennide; Prednisolone; Losartan Potassium; Diastase; Heparin Calcium; Lansoprazole; Pursennide; Levothyroxine Sodium; Renagel



Possible Magnevist side effects in 50 year old female

Reported by a consumer/non-health professional from United States on 2012-06-06

Patient: 50 year old female

Reactions: Anxiety, Emotional Distress, Pain, Nephrogenic Systemic Fibrosis, Injury

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Start date: 2003-08-12
    End date: 2003-08-12



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Emotional Distress, Pruritus Generalised, Anxiety, Anhedonia, Pain, Nephrogenic Systemic Fibrosis, Injury, Deformity, Scar

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-03-01
    End date: 2008-03-01

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-01-30
    End date: 2006-01-30

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-26
    End date: 2006-03-26

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-03-29
    End date: 2006-03-29

Other drugs received by patient: Hectorol; Losartan; Diovan; Epogen; Renagel; Metoprolol Tartrate



Possible Magnevist side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Arthralgia, Gait Disturbance, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Other drugs received by patient: Prednisone; Imuran; Norvasc; Calcium Carbonate; Micardis; Oxycet; Darbepoetin Alfa; Minoxidil; Percocet; Renagel; Digoxin; Clonidine; Phoslo; Lanthanum Carbonate; Ferrlecit; Florinef; Lopressor; Plaquenil; Procardia; Zemplar; Coreg; Amiodarone HCL; Aspirin; Cortisone Acetate; Renaphro; Epogen; Vancomycin; Darbepoetin Alfa; Hectorol; Fosrenol



Possible Magnevist side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Muscular Weakness, General Physical Health Deterioration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Arthralgia, Gait Disturbance, Mobility Decreased, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Other drugs received by patient: Epogen; Renagel; Procardia; Aspirin; Lopressor; Minoxidil; Ferrlecit; Zemplar; Coreg; Norvasc; Calcium Carbonate; Lanthanum Carbonate; Renaphro; Imuran; Digoxin; Florinef; Cortisone Acetate; Plaquenil; Micardis; Amiodarone HCL; Darbepoetin Alfa; Prednisone; Hectorol; Vancomycin; Darbepoetin Alfa; Phoslo; Fosrenol; Clonidine; Percocet; Oxycet



Possible Magnevist side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08

Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)

Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hyperpigmentation, Hypoaesthesia, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Prohance
    Indication: Diagnostic Procedure

Magnevist
    Indication: Diagnostic Procedure

Optimark
    Indication: Diagnostic Procedure

Multihance
    Indication: Diagnostic Procedure

Omniscan
    Indication: Diagnostic Procedure

Contrast Media
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Xalatan; Multivitamins and Iron; Colchicine; Aspirin; Lotrel; Meloxicam; Alphagan; Cosopt; Plavix; Hydrochlorothiazide; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lovenox



Possible Magnevist side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08

Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)

Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Hypoaesthesia, Skin Hyperpigmentation, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Indication: Diagnostic Procedure

Multihance
    Indication: Diagnostic Procedure

Contrast Media
    Indication: Product Used FOR Unknown Indication

Optimark
    Indication: Diagnostic Procedure

Omniscan
    Indication: Diagnostic Procedure

Prohance
    Indication: Diagnostic Procedure

Other drugs received by patient: Plavix; Hydrochlorothiazide; Xalatan; Meloxicam; Colchicine; Aspirin; Lovenox; Cosopt; Alphagan; Multivitamins and Iron; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lotrel



Possible Magnevist side effects in 69 year old male

Reported by a physician from United States on 2012-05-08

Patient: 69 year old male, weighing 99.0 kg (217.8 pounds)

Reactions: Pruritus, Joint Contracture, Pain, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Fibrosis, Extremity Contracture, Peau D'orange, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Tightness, Burning Sensation, Gait Disturbance, Asthenia, Cardiovascular Disorder, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Back Pain
    Start date: 2001-03-20
    End date: 2001-03-20

Magnevist
    Dosage: 10 ml, unk
    Indication: Angioplasty
    Start date: 2002-10-02
    End date: 2002-10-02

Prohance
    Indication: Angiogram

Magnevist
    Dosage: 10 ml, unk
    Start date: 2004-12-02
    End date: 2004-12-02

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2002-02-04
    End date: 2002-02-04

Optimark
    Indication: Angiogram

Multihance
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2001-05-17
    End date: 2001-05-17

Omniscan
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 10 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-25
    End date: 2006-08-25

Magnevist
    Dosage: 20 ml, unk
    Indication: Stent Placement
    Start date: 2003-05-14
    End date: 2003-05-14

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2002-03-27
    End date: 2002-03-27

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 20 ml, unk
    Start date: 2002-09-09
    End date: 2002-09-09

Magnevist
    Dosage: 20 ml, unk
    Start date: 2004-10-19
    End date: 2004-10-19

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Potassium Chloride; Cardura; Aspirin; Norvasc; Demadex; Zetia; Spironolactone; Clonidine; Diltiazem; Epogen; Isosorbide Dinitrate; Quinine Sulfate; Lisinopril; Minoxidil; Nephrocaps



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24

Patient: male, weighing 71.0 kg (156.2 pounds)

Reactions: Pain, Joint Contracture, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Hypertrophy, Muscle Rigidity, Emotional Distress, Anxiety, Anhedonia, Impaired Healing, Musculoskeletal Stiffness, Injury, Disability, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 1999-11-12
    End date: 1999-11-12

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-07-31
    End date: 2001-07-31

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1998-01-15

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2000-06-30
    End date: 2000-06-30

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1997-11-06
    End date: 1997-11-06

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1995-10-02

Other drugs received by patient: Sensipar; Nephrocaps; Toprol-XL; Warfarin Sodium; Lasix; Renagel; MAG-TAB; Prednisone TAB; Iron; Norvasc; Procardia; Inderal; Vasotec; Coumadin; Minoxidil; Lisinopril; Buspar; Midodrine Hydrochloride; Epogen; Immunosuppressive Agents; Digoxin; Lexapro; Fosrenol



Possible Magnevist side effects in female

Reported by a physician from Japan on 2012-04-23

Patient: female

Reactions: Lymphocyte Percentage Decreased, Lymphadenopathy, Pyrexia, Erythema, Liver Disorder, LIP Erosion, Death, C-Reactive Protein Increased, Oral Mucosa Erosion, White Blood Cell Count Increased, Stevens-Johnson Syndrome, Neutrophil Percentage Increased, Vomiting, Rash Generalised, Cytomegalovirus Enterocolitis, Alanine Aminotransferase Increased, Drug Rash With Eosinophilia and Systemic Symptoms, Vulvar Erosion, Diarrhoea, Ocular Hyperaemia, Aspartate Aminotransferase Increased, Rash Maculo-Papular

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Lamictal
    Dosage: 100mg per day
    Administration route: Oral
    Start date: 2011-11-24
    End date: 2011-12-17

Magnevist
    Dosage: 15ml per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-16
    End date: 2011-12-16

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-11-14
    End date: 2011-11-23

Phenytoin Sodium CAP
    Dosage: 250mg per day
    Indication: Epilepsy
    Start date: 2011-11-13
    End date: 2011-11-13

Tegretol
    Dosage: 200mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-11-13
    End date: 2011-11-14



Possible Magnevist side effects in male

Reported by a physician from United States on 2012-03-22

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-10-16
    End date: 2002-10-16

Contrast Media
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-10-16
    End date: 2002-10-16

Magnevist
    Dosage: once
    Indication: Angiogram
    Start date: 2005-01-25
    End date: 2005-01-25

Magnevist
    Dosage: once
    Start date: 2002-11-15
    End date: 2002-11-15

Magnevist
    Dosage: once
    Start date: 2004-07-16
    End date: 2004-07-16

Prohance
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Other drugs received by patient: Insulin Human; Calcium Acetate; Coumadin; Insulin; Temazepam; Clonidine; Diatx; Lasix; Epogen; Sevelamer; Vitamins NOS; Fosrenol; Minoxidil; Accupril



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-22

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Anhedonia, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Prohance
    Dosage: unk unk, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Magnevist
    Dosage: 15 ml, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 19 ml, once
    Start date: 2004-07-16
    End date: 2004-07-16

Magnevist
    Dosage: unk unk, once
    Start date: 2005-01-25
    End date: 2005-01-25

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-15
    End date: 2002-11-15

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Other drugs received by patient: Coumadin; Temazepam; Procrit; Fosrenol; Minoxidil; Novolin R; Insulin [insulin]; Phoslo; Diatx; Vitamins NOS; Accupril; Lasix; Clonidine; Renagel



Possible Magnevist side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21

Patient: 20 year old male, weighing 48.6 kg (106.9 pounds)

Reactions: Skin Exfoliation, Hypertrophy, Joint Contracture, Pain, Abasia, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Depression, Joint Effusion, Extremity Contracture, Pain in Extremity, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Cachexia, Joint Warmth, Asthenia, Mobility Decreased

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-01-21
    End date: 2006-01-21

Omniscan
    Dosage: 30 ml, once
    Indication: Angiogram
    Start date: 2005-06-02
    End date: 2005-06-02

Omniscan

Other drugs received by patient: Enoxaparin; Labetalol HCL; Norvasc; Dantrolene Sodium; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Clonidine HCL; Darbepoetin Alfa; Hydralazine HCL; Fluoxetine; Cefazolin; Renagel; Coumadin



Possible Magnevist side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-20

Patient: female

Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Fibrosis, Deformity, Scar, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Magnevist
    Indication: Imaging Procedure

Optimark
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure



Possible Magnevist side effects in 53 year old female

Reported by a pharmacist from United States on 2012-03-19

Patient: 53 year old female, weighing 114.7 kg (252.4 pounds)

Reactions: Pruritus, Pain, Erythema, Anhedonia, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Injury, Pain in Extremity, Localised Oedema, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Activities of Daily Living Impaired, Skin Mass, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Xopenex; Vasotec; Demedex; Enalapril; Sensipar; Astelin; Phoslo; Vasopressin; Humulin N; Zelnorm; Ativan; Wellbutrin XL; Aspirin; Santyl; Norco; Keppra; Avandia; Allopurinol; Epogen; Aspirin; Torsemide; Neurontin; Hydrocodone Bitartrate and Acetaminophen; Synthroid; Regular Insulin; Renagel; NPH Insulin; Atrovent; Zyloprim; Mirapex; Glucotrol; Ibuprofen



Possible Magnevist side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-28

Patient: 69 year old male, weighing 99.0 kg (217.8 pounds)

Reactions: Pruritus, Pain, Joint Contracture, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Fibrosis, Extremity Contracture, Peau D'orange, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Tightness, Burning Sensation, Gait Disturbance, Asthenia, Cardiovascular Disorder, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2001-05-17
    End date: 2001-05-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Stent Placement
    Start date: 2003-05-14
    End date: 2003-05-14

Magnevist
    Dosage: 10 ml, unk
    Start date: 2004-12-02
    End date: 2004-12-02

Omniscan
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2002-03-27
    End date: 2002-03-27

Magnevist
    Dosage: 10 ml, unk
    Indication: Angioplasty
    Start date: 2002-10-02
    End date: 2002-10-02

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 20 ml, unk
    Start date: 2002-09-09
    End date: 2002-09-09

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Magnevist
    Dosage: 10 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-25
    End date: 2006-08-25

Magnevist
    Dosage: 20 ml, unk
    Start date: 2004-10-19
    End date: 2004-10-19

Magnevist
    Dosage: unk
    Indication: Back Pain
    Start date: 2001-03-20
    End date: 2001-03-20

Prohance
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2002-02-04
    End date: 2002-02-04

Optimark
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Lisinopril; Cardura; Minoxidil; Demadex; Isosorbide Dinitrate



Possible Magnevist side effects in female

Reported by a lawyer from United States on 2012-02-27

Patient: female, weighing 93.4 kg (205.5 pounds)

Reactions: Pain, Skin Disorder, Laceration, Muscular Weakness, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Erythema, Skin Tightness, Arthralgia, Swelling, Musculoskeletal Stiffness, Oedema, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Humulin N; Monopril; Simvastatin; Coreg; Sular; Aspirin; Darvocet; Renagel



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014